FN1 and breast carcinoma: In the present study, hydrophilic surface coating of drug-loaded CA particles by PEG and a cell specific ligand, fibronectin was designed to increase targeting specificity and delivery efficiency of the particle drug complex into breast cancer cells (Figure 12).